Engineers Gate Manager’s Cardiff Oncology CRDF Stock Holding History

Engineers Gate Manager’s Portfolio CRDF Stock Details CRDF Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$32.5K	Buy	+24,994	New	+$39.7K	﹤0.01%	2153
2025 Q3	–	Sell	-13,585	Closed	-$42.8K	–	2224
2025 Q2	$42.8K	Buy	+13,585	New	+$41.4K	﹤0.01%	2057
2022 Q2	–	Sell	-245,567	Closed	-$609K	–	1968
2022 Q1	$609K	Buy	+245,567	New	+$869K	0.02%	955
2021 Q3	–	Sell	-20,109	Closed	-$134K	–	1694
2021 Q2	$134K	Sell	20,109 -62,304	-76%	-$528K	0.01%	1462
2021 Q1	$763K	Buy	+82,413	New	+$1M	0.04%	722

Other funds holding CRDF

LCM

Laurion Capital Management New York $3.9B AUM 75.03% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Pfizer New York $170M AUM 191.09% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

William Blair & Company Chicago, Illinois $38.4B AUM 25.71% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return

Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM

Engineers Gate Manager's CRDF Position: Q2 2026 in Review

Engineers Gate Manager opened a new position in Cardiff Oncology (CRDF) in Q2 2026: 24,994 shares worth $32.5K. The stake represents ﹤0.01% of the portfolio and ranks #2153 among its holdings. This is a return to the name: Engineers Gate Manager previously reported a position in CRDF as recently as Q2 2025.

Engineers Gate Manager first reported a position in CRDF in Q1 2021 and has held it in 5 quarters since. The position peaked at $763K in Q1 2021. 105 funds tracked by Wall St. Rank hold CRDF as of Q2 2026.

Engineers Gate Manager held 24,994 shares of Cardiff Oncology worth $32.5K as of Q2 2026.
Cardiff Oncology was a new Engineers Gate Manager position in Q2 2026.
Cardiff Oncology made up ﹤0.01% of Engineers Gate Manager's portfolio in Q2 2026, its #2153 holding.
Engineers Gate Manager first reported a position in Cardiff Oncology in Q1 2021 and has held it in 5 quarters since.
Engineers Gate Manager's Cardiff Oncology position peaked at $763K in Q1 2021.
105 funds tracked by Wall St. Rank held Cardiff Oncology as of Q2 2026.

Based on Engineers Gate Manager's 13F filing for Q2 2026, filed 14 Aug 2026.